# Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension

> **NCT01316666** · — · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Orthostatic Hypotension
- Pure Autonomic Failure
- Multiple System Atrophy
- Parkinson's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01316666
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01316666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01316666, "Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01316666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*